VRCA

2.7405.03%
MA

Mark A. Prygocki

Independent Director

Mr. Mark A. Prygocki, Sr., served as the President of Medicis Pharmaceutical Corp. from July 2010 to December 2012. Mr. Prygocki served as an Executive Vice President of Medicis Pharmaceutical Corp. from January 2001 to July 1, 2010. He served as the Chief Financial Officer and a Treasurer of Medicis Pharmaceutical Corp., from May 1995 to April 2008. He served as the Chief Accounting Officer of Medicis Pharmaceutical Corp. until April 2008 and its Corporate Secretary from May 1995 to July 12, 2006. Mr. Prygocki served as the Controller of Medicis from October 1991 to May 1995. He served as a Senior Vice President of Finance of Medicis. Mr. Peterson also served various accounting and finance related positions since joining Medicis in 1995, including Vice President of Finance since 2002. He had been an Independent Director of Clarus Therapeutics Holdings, Inc. since September 9, 2021 until October 31, 2022 and served as a member of Legacy Clarus’s board of directors from July 2014 through the Merger Closing and as executive director from July 2020 through May 2021. He has been an Independent Director of Verrica Pharmaceuticals Inc. since May 2018. He served as an Independent Director of Revance Therapeutics, Inc. from May 12, 2014 to May 11, 2017. From July 1990 to October 1991, Mr. Prygocki served at Citigroup, an investment banking firm, in the Regulatory Reporting Division. rior to Medicis, he served at Salomon Smith Barney, Inc., and served for several years in the Audit department of Ernst & Young LLP. He serves on the Boards of Foothills Foundation and Whispering Hope Ranch Foundation and Visions of Hope, Inc. He is a Member of the Financial Executive Institute. He is certified by the Arizona State Board of Accountancy and the New York Society of CPAs. Mr. Prygocki holds a B.A. in accounting from Pace University.

Positions